换一批
第一作者：
Stewart,Abbot
第一单位：
Fate Therapeutics, USA.
作者：
Stewart,Abbot [1]
;
Francisca,Agbanyo [2]
;
Jan-Eric,Ahlfors [3]
;
Behnam A,Baghbaderani [4]
;
Shirley,Bartido [5]
;
Kapil,Bharti [6]
;
Carl,Burke [7]
;
Bjorn,Carlsson [8]
;
Joy,Cavagnaro [9]
;
Abla,Creasey [10]
;
David,DiGiusto [11]
;
Kathy,Francissen [12]
;
Andrew,Gaffney [13]
;
Christopher,Goldring [14]
;
Thorsten,Gorba [15]
;
Elwyn,Griffiths [16]
;
Tadaaki,Hanatani [17]
;
Takao,Hayakawa [18]
;
Tatsuo,Heki [19]
;
Karin,Hoogendoorn [20]
;
Shin,Kawamata [21]
;
Hironobu,Kimura [22]
;
Agnete,Kirkeby [23]
;
Ivana,Knezevic [24]
;
Jane,Lebkowski [25]
;
Stephen,Lin [10]
;
Shen,Lin-Gibson [26]
;
Anthony,Lubiniecki [16]
;
Orla,O'Shea [27]
;
Martin,Pera [28]
;
John,Petricciani [29]
;
Gary,Pigeau [30]
;
Anthony,Ratcliffe [31]
;
Yoji,Sato [32]
;
Gerald G,Schumann [33]
;
William,Shingleton [34]
;
Glyn,Stacey Chair [35]
;
Stephen,Sullivan [36]
;
Clive N,Svendsen [37]
;
Jean-Hugues,Trouvin [38]
;
Joris,Vandeputte [16]
;
Bao-Zhu,Yuan [39]
;
Kathryn,Zoon [40]
作者单位：
Fate Therapeutics, USA.
[1]
Health Canada, Canada.
[2]
Fortuna Fix, Canada.
[3]
Lonza, Emerging Technologies, USA.
[4]
Cellectis, USA.
[5]
National Institutes of Health (NIH), USA.
[6]
Janssen Pharmaceuticals, USA.
[7]
Medical Products Agency, Sweden.
[8]
Access BIO, USA.
[9]
California Institute for Regenerative Medicine (CIRM), USA.
[10]
Stanford University School of Medicine, USA.
[11]
Genentech, USA.
[12]
STEMCELL Technologies, Canada.
[13]
University of Liverpool, UK.
[14]
IQVIA, USA.
[15]
International Alliance for Biological Standardization (lABS), Switzerland.
[16]
Kyoto University, Japan.
[17]
Osaka University, Japan, Kindai University, Japan.
[18]
Fujifilm, Japan.
[19]
Leiden University Medical Center, the Netherlands.
[20]
Foundation for Biomedical Research and Innovation (FBRI), Japan.
[21]
HEALIOS K.K., Japan.
[22]
University of Lund, Sweden and University of Copenhagen, Denmark.
[23]
World Health Organisation (WHO), Switzerland.
[24]
Regenerative Patch Technologies, USA.
[25]
National Institute of Standards and Technology, USA.
[26]
National Institute for Biological Standards and Control (NIBSC), UK.
[27]
International Stem Cell Initiative, Jackson Laboratories, USA.
[28]
International Alliance for Biological Standardization (lABS), Switzerland. Electronic address: jpmdpsca@aol.com.
[29]
Centre for Commercialization of Regenerative Medicine (CCRM), Canada.
[30]
Standard Coordinating Body, USA.
[31]
National Institute of Health Sciences, Japan.
[32]
Paul-Ehrlich-Institute, Germany.
[33]
GE Healthcare, UK.
[34]
University of Liverpool, UK; International Stem Cell Banking Initiative (ISCBI), UK.
[35]
Global Alliance for IPSC Therapies (GAiT), UK.
[36]
Cedars-Sinai Medical Center, USA.
[37]
Paris Descartes University, France.
[38]
National Institutes for Food and Drug Control, China.
[39]
National Institutes of Health (NIH), Emerita, USA.
[40]
医学主题词
致癌性试验(Carcinogenicity Tests);指导方针(主题)(Guidelines as Topic);人类(Humans);多潜能干细胞(Pluripotent Stem Cells);质量控制(Quality Control);再生医学(Regenerative Medicine)
DOI
10.1016/j.biologicals.2018.08.004
PMID
30150108
发布时间
2025-07-19
- 浏览23
Biologicals
Biologicals
67-83页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
